|
1
|
Kouijzer IJE, van Leerdam EJ, Gompelman M, Tuinte RAM, Aarntzen EHJG, Berrevoets MAH, Maat I, Bleeker-Rovers CP, van Crevel R, Ten Oever J. Intravenous to oral switch in complicated Staphylococcus aureus bacteremia without endovascular infection: a retrospective single-center cohort study. Clin Infect Dis 2021; 73:895-898. [PMID: 33606007 PMCID: PMC8423458 DOI: 10.1093/cid/ciab156] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2020] [Accepted: 02/15/2021] [Indexed: 01/12/2023] Open
Abstract
In this retrospective cohort study, selected patients with disseminated Staphylococcus aureus bacteremia, but without endovascular infection on echocardiography and 18F-FDG-PET/CT, were free of relapse after IV-oral switch. Mortality was low and similar to patients who received prolonged intravenous treatment. IV-oral switch was associated with a shorter length of hospital stay.
Collapse
Affiliation(s)
- Ilse J E Kouijzer
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud university medical center, Nijmegen, the Netherlands
| | - Eline J van Leerdam
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud university medical center, Nijmegen, the Netherlands
| | - Michelle Gompelman
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud university medical center, Nijmegen, the Netherlands.,Department of Gastroenterology and Hepatology, Radboud university medical center, Nijmegen, The Netherlands
| | - Renee A M Tuinte
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud university medical center, Nijmegen, the Netherlands
| | - Erik H J G Aarntzen
- Department of Radiology and Nuclear Medicine, Radboud university medical center, Nijmegen, the Netherlands
| | - Marvin A H Berrevoets
- Department Internal Medicine, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands
| | - Ianthe Maat
- Department of Medical Microbiology and Radboud Center for Infectious Diseases, Radboud university medical center, Nijmegen, the Netherlands
| | - Chantal P Bleeker-Rovers
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud university medical center, Nijmegen, the Netherlands
| | - Reinout van Crevel
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud university medical center, Nijmegen, the Netherlands
| | - Jaap Ten Oever
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud university medical center, Nijmegen, the Netherlands
| |
Collapse
|
|
2
|
Iwarson S, Fasth S, Olaison L, Hultén L. Adverse reactions to intravenous administration of fusidic acid. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES 1981; 13:65-7. [PMID: 7244561 DOI: 10.1080/00365548.1981.11690369] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
To study adverse reactions associated with intravenous administration of fusidic acid 6 patients were treated with fusidic acid intravenously in association with a major large bowl operation, and 9 patients were treated in the same way because of staphylococcal infections. The main adverse reaction was thrombophlebitis, which occurred in as many as 12 of 14 patients who were treated for 2 days or longer. Three surgical patients developed postoperative hyperbilirubinaemia, but studies of liver function before and during treatment in 6 of the patients with staphylococcal disease revealed no adverse liver reactions. Intravenous administration of fusidic acid into a peripheral vein for 24 h or more involves an extremely high risk of developing thrombophlebitis.
Collapse
|